International Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Investigator-Initiated Clinical Trial to Evaluate the Efficacy and Safety of Fufang Xiolingdan Mixture in Patients with Influenza (Wind-Heat Invasion Syndrome)

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122292) titled 'A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Investigator-Initiated Clinical Trial to Evaluate the Efficacy and Safety of Fufang Xiolingdan Mixture in Patients with Influenza (Wind-Heat Invasion Syndrome)' on April 11.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Kunming Municipal Hospital of Traditional Chinese Medicine

Condition: Flu(influenza)

Intervention: Trial Group:Compound Xianlingdan Mixture, oral, 30ml each time, three times daily

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-20

Target Sample Size: Trial Group:60;...